CareMax, Inc.

NASDAQ:CMAX

2.09 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 198.627232.246151.835201.843224.44172.983164.263157.67172.279136.92118.306104.6244.91927.91828.08724.30625.79525.1825.425
Cost of Revenue 49.10649.83849.777182.965197.187149.3142.801137.113150.712120.205102.46794.93143.40223.51222.06921.64519.84416.15715.804
Gross Profit 149.521182.408102.05818.87827.25323.68321.46220.55721.56716.71515.8399.6891.5174.4066.0182.6615.9519.0239.62
Gross Profit Ratio 0.7530.7850.6720.0940.1210.1370.1310.130.1250.1220.1340.0930.0340.1580.2140.1090.2310.3580.378
Reseach & Development Expenses 0000000000000000000
General & Administrative Expenses 14.7820.10816.66319.28220.79523.94517.09621.68718.06318.97816.31513.5898.8811.7953.1221.8851.456011.393
Selling & Marketing Expenses 1.3783.0643.6813.5013.3273.7653.8062.3552.2993.3012.6141.2740.7750.2910.2560.3110.27200.643
SG&A 169.543202.68183.96422.78324.12227.7120.90224.04220.36222.27918.92914.8639.6567.6733.3782.1961.7285.5248.817
Other Expenses 0.3820.611.41269.8320.5346.5767.184.5734.9035.062-0.493-0.841.4370.5140.4290.3590.35600
Operating Expenses 169.543202.68183.964292.61530.9534.28628.08228.61525.26527.34125.01820.03911.09326.1123.8072.5552.0845.5248.817
Operating Income -20.022-20.272-81.906-117.3-3.75-10.603-5.654-8.0583.648-10.626-9.674-11.229-9.7251.8062.2110.1063.8673.4980.803
Operating Income Ratio -0.101-0.087-0.539-0.581-0.017-0.061-0.034-0.0510.021-0.078-0.082-0.107-0.2170.0650.0790.0040.150.1390.032
Total Other Income Expenses Net -150.359-22.959-385.25614.354-15.306-71.301-3.986-13.814-12.857-5.9927.6918.7873.004-0.504-0.993-0.387-0.403-0.327-0.72
Income Before Tax -170.381-43.231-467.162-102.946-32.2-81.904-9.64-21.872-9.209-16.618-3.393-2.854-7.3641.3021.218-0.2813.4643.1710.083
Income Before Tax Ratio -0.858-0.186-3.077-0.51-0.143-0.473-0.059-0.139-0.053-0.121-0.029-0.027-0.1640.0470.043-0.0120.1340.1260.003
Income Tax Expense 0.1770.177-1.395-0.1770.1770.177-20.0740.1810.1710.1810.1590.451-2.212-0-0.0530.0340.082-0.09-0.141
Net Income -170.558-43.408-465.767-103.123-32.376-82.08110.434-22.053-9.38-16.799-3.553-2.854-7.3641.3021.273-0.3153.3823.2610.224
Net Income Ratio -0.859-0.187-3.068-0.511-0.144-0.4750.064-0.14-0.054-0.123-0.03-0.027-0.1640.0470.045-0.0130.1310.130.009
EPS -44.79-11.49-124.53-27.6-8.7-22.113.1-7.57-3.3-5.77-1.23-1.06-7.253.623.54-0.99.48.9670.616
EPS Diluted -44.79-11.49-124.53-27.6-8.7-22.113.06-7.57-3.22-5.77-1.22-1.04-7.153.63.3-0.889.39.0610.622
EBITDA -10.859-10.892-71.701-110.4679.507-4.0931.526-3.3988.551-6.026-11.274-6.006-11.1342.322.640.4684.2233.8551.203
EBITDA Ratio -0.055-0.047-0.472-0.5470.042-0.0240.009-0.0220.05-0.044-0.095-0.057-0.2480.0830.0940.0190.1640.1530.047